SLC1A5 and breast carcinoma: As the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D) downregulates SLC1A5 and reduces glutamine uptake and utilization in Harvey-ras oncogene-transformed MCF10A human breast epithelial cells, potentially contributing to breast cancer prevention.